Seven generic drug manufacturers sign royalty-free agreements to produce experimental once-monthly HIV pill

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.

Aspen Pharmacare has secured a licensing agreement with MSD for alimatravir, a promising once-monthly oral medication aimed at preventing HIV-1, which could revolutionise access…